Nathan Brower, Executive Vice President of Nature’s Sunshine Products (NASDAQ:NATR), sold 3,800 shares of the company’s stock on November 14, 2023. The shares were sold at an average price of $20.81, resulting in a total transaction value of $79,078.00. Following this transaction, Brower holds 46,735 shares of the company, valued at approximately $972,555.35. This sale represents a 7.52% decrease in his holdings.
The transaction was disclosed in a filing with the Securities and Exchange Commission, providing transparency to investors and stakeholders. The share sale comes at a time when Nature’s Sunshine Products is navigating a competitive market landscape.
Nature’s Sunshine Products Stock Overview
On November 14, 2023, shares of Nature’s Sunshine Products traded up by $0.29, reaching $20.82. A total of 104,898 shares changed hands, surpassing the company’s average trading volume of 79,336 shares. Over the past year, the stock has experienced significant fluctuations, with a low of $11.01 and a high of $21.64. The company currently has a market capitalization of $364.27 million, a price-to-earnings (P/E) ratio of 28.14, and a beta of 1.09, indicating its market volatility compared to the broader market.
The firm’s 50-day moving average stands at $15.85, while the 200-day moving average is noted at $15.41. Nature’s Sunshine Products recently announced its quarterly earnings on November 6, 2023, reporting earnings per share (EPS) of $0.36. This result exceeded the consensus estimate of $0.18, showing a significant positive variance.
Institutional Investor Activity
Recent trading activity reflects changes among institutional investors regarding their stakes in Nature’s Sunshine Products. Notably, Ameriprise Financial Inc. increased its ownership by 1.4% during the second quarter, now holding 54,008 shares valued at $799,000. Similarly, CWM LLC expanded its position by 147.0% in the third quarter, owning 2,075 shares worth $32,000.
Other institutional movements include First Trust Advisors LP, which raised its stake by 3.4%, owning 39,099 shares valued at $578,000. Additionally, Strs Ohio and Rhumbline Advisers increased their respective holdings by 4.2% and 9.7%, now owning 35,100 shares and 21,180 shares, valued at $545,000 and $313,000 respectively. Currently, institutional and hedge fund ownership accounts for 79.40% of the company’s stock.
Nature’s Sunshine Products operates in the health and wellness sector, offering a range of nutritional and personal care products across multiple regions, including Asia, Europe, North America, and Latin America. The company specializes in products related to various health aspects, such as blood sugar support, joint health, and cognitive function.
This sale by Brower and the activity among institutional investors highlight the ongoing interest in Nature’s Sunshine Products as it continues to navigate its operational challenges and market opportunities.
